Management of Locally Advanced Esophageal Cancer

Authors

  • Binay Thakur Department of Surgical Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Mukti Devkota Department of Surgical Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Manish Chaudhary Department of Surgical Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal

DOI:

https://doi.org/10.31729/jnma.4299

Keywords:

combined modality therapy, esophageal cancer, esophagectomy

Abstract

Esophageal cancer is diagnosed usually at a locally advanced stage. Surgery alone has less optimal results and a multimodality approach has been established as the standard of care for cII-III stages of esophageal cancer. This review focuses on the recent evidences of management of esophageal cancer with various variations in approaches in Eastern and Western countries. The major difference is the selection of induction treatment. Till the results of some ongoing trials become available, most of the evidences support neoadjuvant chemoradiation followed by surgery for squamous cell carcinoma and perioperative chemotherapy and surgery for adenocarcinoma.

Author Biography

Binay Thakur, Department of Surgical Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal

|

Downloads

Published

2021-04-30

How to Cite

Thakur, B., Devkota, M., & Chaudhary, M. (2021). Management of Locally Advanced Esophageal Cancer. Journal of Nepal Medical Association, 59(236), 409–416. https://doi.org/10.31729/jnma.4299

Issue

Vol. 59 No. 236 (2021): JNMA: Published Monthly

Section

Review Article

License

Copyright (c) 2021 Binay Thakur, Mukti Devkota, Amit Sharma, Manish Chaudhary

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.

Most read articles by the same author(s)